M agnetic resonance urography (MRU) is a noninvasive imaging technique that does not involve ionizing radiation or iodinated contrast medium. Therefore, it has a potential to noninvasively illustrate various urinary tract abnormalities and provides both morphologic and functional information. MRU can be obtained by two different techniques: T2-weighted MRU (also known as static-fluid MRU) and T1-weighted MRU (also known as contrast-enhanced excretory MRU) (1-3). Generally used contrast-enhanced MRU protocol with single-bolus contrast material injection consists of dynamic scanning of urinary system at different phases. However, using the single bolus technique, vessels and collecting systems cannot be demonstrated simultaneously. Although split bolus computed tomography (CT) urography is widely used in adults and described in the literature, the major disadvantage in multiphasic scans and follow-up is the radiation exposure, particularly in pediatric patients who are more susceptible to radiation-related effects including cancer and mutations. Compared with adults, children are considerably more sensitive to radiation and have a longer life expectancy resulting in a larger window for expressing radiation damage (4). Moreover, the administration of potentially nephrotoxic iodinated contrast agents in this group that are prone to renal impairment is an important restriction for CT urography (2).
dependent of renal function and can be used to evaluate dilated urinary system in poorly functioning or nonfunctioning kidneys. T2-weighted MRU is an important tool to demonstrate urinary system pathologies in childhood because of high contrast resolution and no radiation. T2-weighted MRU images can be obtained as a single thick slab or MIP views generated from multiple thin slice 3D T2-weighted images (1) (2) (3) 5) ; but, T2-weighted sequences do not provide functional information (Fig. 2) .
For MRU studies, patients are hydrated with saline infusion starting 30 minutes prior to examination. The children under the age of seven years may require i.v. sedation or general anesthesia. MRU examinations can be performed with either 1.5 T or 3.0 T MRI scanners using phased-array body coils. MRU protocol begins with localizing sequences and continues with conventional axial and coronal 2D T1 and T2-weighted MRI sequences to assess the renal parenchyma and periurinary area. Then MRU protocol continues with thickslab single and multislice 3D T2-weighted MRU sequences. Subsequently, 0.3 mg/ kg furosemide and 0.1 mmol/kg of gadolinium-based contrast agent are given intravenously at the same time. There have been different timing techniques of gadolinium and furosemide injection. Furosemide has been injected before, after, or at the same time with gadolinium on different studies. We obtained good opacification with the latter technique and avoided patient discomfort due to early bladder filling. Furosemide is administered to dilate the collecting system by increasing glomerular filtration rate and to reduce the T2* effect of intravenously administered contrast agent. Patients are examined in the coronal plane during the vascular and nephropyelographic phase (at 15 seconds, and 1, 3, and 5 minutes) using coronal 3D T1-weighted gradient echo (GRE) sequences. This sequence can be repeated until the ureters and bladder opacify completely. Upon completion of the above-mentioned sequences, multislice heavily T2-weighted and 3D T1-weighted images are reconstructed by multiplanar reconstruction (MPR) and converted by MIP to generate i.v. urogram-like images. However, with this MRU technique it is not feasible to visualize the renal vasculature and collecting system concurrently since there is not enough contrast available in the renal arteries at the renal excretory phase of the contrast. In addition, if serial postcontrast scans are obtained, it is possible to measure differential renal function and create time-signal intensity curves similar to those used in scintigraphy.
With split-bolus MRU, the aforementioned MRU technique can be modified by splitting the i.v. gadolinium dose. Following the precontrast MRU sequence, only one third of the total contrast dose is given with the furosemide and 3D T1-weighted gradient GRE sequence is implemented to obtain arteriographic phase images.
Five to ten minutes after the first contrast injection (when urinary collecting system visualization is sufficient on T1-weighted MRU images), the second dose of i.v. contrast medium is administered (two-thirds of the total dose). The urinary system is examined again in the coronal plane during the arterial and venous phase by repeating the 3D T1-weighted GRE sequences to image the renal vasculature and collecting system. Following these, dynamic scan, MPR, and MIP images are generated. Fig.  3 provides an imaging scheme for the split-bolus MRU technique. Total study time is about 40-45 minutes; additional 30 minutes is necessary for post-processing. It would be possible to calculate differential renal function by acquiring serial scans after the first dose of gadolinium, but this increases the study time further. Regarding functional assessment, some researchers suggested that as low as one fourth of total dose of gadolinium eliminates the T2* effect and gives more consistent functional results (6) . Therefore, we think lower amount of i.v. contrast would not be a disadvantage for functional estimation. Similar to functional imaging, the authors' experience suggests that splitting contrast dose provided diagnostic angiographic and urographic images.
Two discrete boluses of i.v. contrast medium are administered at separate times. First, one-third dose of i.v. contrast is used to image
Main points
• MR urography can provide both morphologic and functional information about urinary tract by using two-dimensional and three-dimensional T1-and T2-weighted sequences.
• With split-bolus MR urography, two discrete boluses of intravenous (i.v.) contrast medium are administered at separate times.
• First dose of i.v. contrast allows imaging the urinary tract at different phases including vascular, parenchymal, and excretory phases. Second dose of i.v. contrast with scanning at arterial and venous phases provides both vascular and excretory phase information.
• This method provides synchronous visualization of vascular and excretory phase enhancement, and can be used to illustrate pathologies such as the nutcracker syndrome, crossing renal vessels and retroiliac ureters that may be responsible for obstruction of the urinary collecting system. the urinary tract at different phases including vascular, parenchymal, and excretory phases. Second, the remaining two-thirds dose of i.v. contrast is used while scanning at the arterial and venous phase to provide both vascular and excretory phase information. Kidneys can concentrate the i.v. contrast medium in up to 200 times of the plasma level; therefore we prefer to split the dose into an initial one-third followed by a twothirds bolus. This method provides synchronous visualization of vascular and excretory phase enhancement, and can be used to determine pathologies such as the nutcracker syndrome, crossing renal vessels, and retroiliac ureters that may be responsible for the urinary collecting system obstruction.
Applications of split-bolus MRU Crossing renal vessels
Although congenital ureteropelvic junction (UPJ) obstruction is usually secondary to abnormal musculature of the UPJ, in patients with UPJ obstruction, the percentage of crossing vessels has been estimated to be as high as 79% (7). Crossing vessels may be a prominent artery, vein, or both. They are most commonly located anterior to the UPJ, but posteriorly crossing vessels can also be seen (7). Crossing vessels at the level of UPJ can cause or worsen obstruction and complicate endoscopic management.
Differentiation between the anterior and posterior vessels or identification of the small vein in contact with the UPJ is a frequent problem in diagnosis and management of crossing renal vessels (5, (8) (9) (10) . The success rate of the endoscopic treatment method significantly drops in the presence of a crossing vessel. In addition, an unrecognized crossing vessel can also result in significant hemorrhage during endoscopic procedure (11) . Accurate preoperative identification of a crossing vessel is crucial for the appropriate treatment approach (5, 9-11). Although there are some important signs like hooked or deformed upper ureter in diagnosis of the crossing vessel in i.v. urography, conventional MRI, MRU, and split-bolus MRU can provide excellent simultaneous 3D visualization of the crossing renal vessel and its relationship with the urinary collecting system (Figs. 4-6 
Retroiliac ureters
Retroiliac ureter is a rare congenital cause of noncalculous low ureteral obstruction, and it is mostly unilateral. This entity occurs due to faulty migration of the kidney during embryologic development. Retroiliac location of the ureter may lead to infection or hematuria due to venous congestion of the ureteral mucosa by the external arterial compression. Preoperative diagnosis of this entity is usually challenging and requires high level of suspicion (Fig. 7) . A retroiliac ureter should be suspected in patients with varying degrees of upper urinary tract dilatation, especially if the diagnosis is undetermined in excretory urography and ultrasonography (12) . Split-bolus MRU technique provides precise diagnosis by simultaneous 3D visualization of the compressed ureter and compressing iliac artery, and abnormal course of the ureter behind the iliac artery.
Nutcracker phenomenon/syndrome
Nutcracker phenomenon, also called the left renal vein (LRV) entrapment, is characterized by impeded outflow from the LRV accompanied by distension of the distal portion of the vein. The nutcracker syndrome is the clinical equivalent of nutcracker phenomenon characterized by symptoms varying from asymptomatic microhematuria to severe pelvic congestion (13) .
There are two types of nutcracker syndrome. In the most common type, also known as the anterior nutcracker syndrome, the LRV is compressed between the aorta and superior mesenteric artery. In the less common type, also known as the posterior nutcracker syndrome, the retro-aortic or circumaortic LRV is compressed between the aorta and the vertebral body. Diagnosis of the nutcracker syndrome is difficult and frequently delayed (13, 14) . Split-bolus MRU can provide excellent simultaneous 3D demonstration of urinary collecting system, arterial structures (aorta and superior mesenteric artery), renal venous structures (in general arterial phase provides sufficient enhancement of the renal veins to diagnose the renal vein abnormalities), and surrounding soft tissue and bony structures (Fig. 8) .
Ovarian vein syndrome
Ovarian vein syndrome is a relatively rare and probably underdiagnosed condition. In this syndrome, a dilated ovarian vein compressing the ureter leads to its stenosis or obstruction, and dilatation of the collecting system. The most important etiologic factor is parity, which is associated with ovarian vein reflux, dilation and varicosity of the ovarian vein, or ovarian vein thrombosis. Ovarian vein syndrome is an extremely rare condition in a child (15) . The right ovarian vein is the most frequently affected, although this entity can also affect the left side or both sides. Imaging studies such as i.v. urography, ultrasonography, CT, or MRI supports the diagnosis; but it remains a diagnosis of exclusion of other conditions causing similar symptoms (15) . Split-bolus MRU can show simultaneous visualization of the compressed ureter and enlarged ovarian vein.
Conclusion
It is essential to select the accurate imaging technique to evaluate a specific clinical condition. By splitting the contrast medium into two separate bolus injections, MRU can demonstrate the urinary collecting system and vessels simultaneously, and allow preoperative radiologic diagnosis of obstructing vessel noninvasively and without radiation exposure. a c b 
